DURATION OF DRUG LEVELS IN MICE AS INDICATED BY RESIDUAL ANTILEUKEMIC EFFICACY

被引:40
作者
KLINE, I
GANG, M
TYRER, DD
MANTEL, N
VENDITTI, JM
GOLDIN, A
机构
关键词
D O I
10.1159/000220528
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:28 / &
相关论文
共 20 条
[1]  
CHIRIGOS MA, 1962, CANCER RES, V22, P187
[2]  
CHIRIGOS MA, 1965, CANCER CHEMOTH REP, P15
[3]  
FOLEY GE, 1961, CANCER RES, V21, P57
[4]  
GOLDIN A, 1956, J NATL CANCER I, V17, P203
[5]  
GOLDIN A, 1962, CANCER RES, V22, P749
[6]   CANCER CHEMOTHERAPY WITH PURINE AND PYRIMIDINE ANALOGUES [J].
HEIDELBERGER, C .
ANNUAL REVIEW OF PHARMACOLOGY, 1967, 7 :101-+
[7]   SYNTHESIS OF POTENTIAL ANTICANCER AGENTS .36. N-NITROSOUREAS .2. HALOALKYL DERIVATIVES [J].
JOHNSTON, TP ;
MCCALEB, GS ;
OPLIGER, PS ;
MONTGOME.JA .
JOURNAL OF MEDICINAL CHEMISTRY, 1966, 9 (06) :892-+
[8]  
KENSLER CJ, 1963, CANCER RES, V23, P1353
[9]  
KENSLER CJ, 1965, CANCER RES, V25, P1622
[10]  
KLINE I, 1966, CANCER RES, V26, P853